Correspondence 0001683168-25-002552 from CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc.
Date: April 14, 2025 · CIK: 0001729427 · Accession: 0001683168-25-002552
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286529
Letter
A.G.P. / Alliance Global Partners
590 Madison Ave., 28 th Floor
New York, NY 10022
April 14, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: CNS Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-286529
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), A.G.P / Alliance Global Partners as sole Placement Agent, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on Wednesday, April 16, 2025 or as soon thereafter as practicable.
Very truly yours,
A.G.P / Alliance Global Partners
Show Raw Text
CORRESP 1 filename1.htm A.G.P. / Alliance Global Partners 590 Madison Ave., 28 th Floor New York, NY 10022 April 14, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: CNS Pharmaceuticals, Inc. Registration Statement on Form S-1 File No. 333-286529 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), A.G.P / Alliance Global Partners as sole Placement Agent, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on Wednesday, April 16, 2025 or as soon thereafter as practicable. Very truly yours, A.G.P / Alliance Global Partners By: /s/ Thomas J. Higgins Name: Thomas J. Higgins Title: Managing Director